Martin Tolar
Framingham State University(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Cholinesterase and Neurodegenerative Diseases, Amyloidosis: Diagnosis, Treatment, Outcomes, Intracerebral and Subarachnoid Hemorrhage Research
Most-Cited Works
- → Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval(2020)347 cited
- → The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis(2019)278 cited
- → Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression(2021)210 cited
- → Truncated Apolipoprotein E (ApoE) Causes Increased Intracellular Calcium and May Mediate ApoE Neurotoxicity(1999)148 cited
- → Spatial navigation testing discriminates two types of amnestic mild cognitive impairment(2009)144 cited
- → Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease(2017)123 cited
- → Neurotoxicity of the 22 kDa Thrombin-Cleavage Fragment of Apolipoprotein E and Related Synthetic Peptides Is Receptor-Mediated(1997)116 cited
- → Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer’s Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data(2017)105 cited
- → Human Analogue of the Morris Water Maze for Testing Subjects at Risk of Alzheimer’s Disease(2010)97 cited
- → A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity(1996)97 cited